1. Home
  2. FATN vs CRBP Comparison

FATN vs CRBP Comparison

Compare FATN & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATN
  • CRBP
  • Stock Information
  • Founded
  • FATN 1989
  • CRBP 2009
  • Country
  • FATN United States
  • CRBP United States
  • Employees
  • FATN N/A
  • CRBP N/A
  • Industry
  • FATN
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FATN
  • CRBP Health Care
  • Exchange
  • FATN NYSE
  • CRBP Nasdaq
  • Market Cap
  • FATN 109.0M
  • CRBP 96.5M
  • IPO Year
  • FATN 2025
  • CRBP N/A
  • Fundamental
  • Price
  • FATN $8.87
  • CRBP $8.22
  • Analyst Decision
  • FATN
  • CRBP Strong Buy
  • Analyst Count
  • FATN 0
  • CRBP 10
  • Target Price
  • FATN N/A
  • CRBP $53.56
  • AVG Volume (30 Days)
  • FATN 39.9K
  • CRBP 214.0K
  • Earning Date
  • FATN 01-01-0001
  • CRBP 08-05-2025
  • Dividend Yield
  • FATN N/A
  • CRBP N/A
  • EPS Growth
  • FATN N/A
  • CRBP N/A
  • EPS
  • FATN 0.15
  • CRBP N/A
  • Revenue
  • FATN $16,288,881.00
  • CRBP N/A
  • Revenue This Year
  • FATN N/A
  • CRBP N/A
  • Revenue Next Year
  • FATN N/A
  • CRBP $150.03
  • P/E Ratio
  • FATN $60.75
  • CRBP N/A
  • Revenue Growth
  • FATN N/A
  • CRBP N/A
  • 52 Week Low
  • FATN $5.60
  • CRBP $4.64
  • 52 Week High
  • FATN $23.27
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • FATN N/A
  • CRBP 54.23
  • Support Level
  • FATN N/A
  • CRBP $7.26
  • Resistance Level
  • FATN N/A
  • CRBP $7.90
  • Average True Range (ATR)
  • FATN 0.00
  • CRBP 0.53
  • MACD
  • FATN 0.00
  • CRBP -0.01
  • Stochastic Oscillator
  • FATN 0.00
  • CRBP 78.59

About FATN FATPIPE INC

Fatpipe Inc is a pioneer in enterprise-class, application-aware, secure SD-WAN solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. It is engaged in delivering principal enterprise-class networking software technology. The company is dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Its commitment lies in empowering its customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. Further, the company's goal is to ensure its customers have unparalleled insights into their network operations.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: